Gene: MKLN1
Official Full Name: muskelin 1provided by HGNC
Gene Summary: Muskelin is an intracellular protein that acts as a mediator of cell spreading and cytoskeletal responses to the extracellular matrix component thrombospondin I (MIM 188060) (Adams et al., 1998 [PubMed 9724633]).[supplied by OMIM, Mar 2008]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO36625 | MKLN1 Knockout cell line (HeLa) | Human | MKLN1 | 1:3~1:6 | Negative | Online Inquiry |
KO36626 | MKLN1 Knockout cell line (HCT 116) | Human | MKLN1 | 1:2~1:4 | Negative | Online Inquiry |
KO36627 | MKLN1 Knockout cell line (HEK293) | Human | MKLN1 | 1:3~1:6 | Negative | Online Inquiry |
KO36628 | MKLN1 Knockout cell line (A549) | Human | MKLN1 | 1:3~1:4 | Negative | Online Inquiry |
MKLN1 Gene Knockout Cell Lines are specifically engineered cellular models wherein the MKLN1 gene, implicated in various biological processes, has been inactivated or 'knocked out'. These cell lines serve as powerful tools in molecular biology, enabling researchers to investigate the functional role of the MKLN1 gene in cellular mechanisms such as proliferation, differentiation, and apoptosis. By observing the phenotypic changes and altered signaling pathways in response to MKLN1 depletion, scientists can unravel the gene's contribution to both normal physiology and disease states.
The key functions of MKLN1 involve its regulatory impact on cytoskeletal dynamics and cell-cell interactions. Deactivation of MKLN1 allows for a clearer understanding of its involvement in processes like cell migration and adhesion, thereby contributing essential insights into cancer metastasis and tissue engineering. This targeted disruption of gene function not only helps elucidate pathways of interest but also serves as a model for investigating potential therapeutic applications.
From a scientific perspective, MKLN1 Gene Knockout Cell Lines provide significant value in research arenas such as oncology, developmental biology, and regenerative medicine. They can facilitate the validation of drug targets and aid in the functional analysis of gene networks in health and disease. The specificity of these cell lines allows for controlled experimental conditions that are crucial for reproducibility and reliability in research outcomes.
What sets MKLN1 Gene Knockout Cell Lines apart from competing products is their rigorous development process and comprehensive characterization, ensuring consistent, high-quality results suitable for a wide range of applications. Additionally, they come with detailed supporting documentation and protocols, enabling ease of use for researchers at various skill levels.
Investing in MKLN1 Gene Knockout Cell Lines not only streamlines the research process but also elevates the quality of results through advanced genetic manipulation. Researchers and clinicians alike will benefit from these precision models, enhancing their ability to make groundbreaking discoveries and develop innovative therapies.
Our company prides itself on its expertise in genetic research products, offering a diverse range of biological tools that empower the scientific community. With a commitment to quality and innovation, we continuously strive to support researchers in their quest for discoveries that can transform healthcare and advance our understanding of fundamental biological processes.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.